Nyob Kho Dua Tshiab Cov Xov Xwm Thoob Ntiaj Teb Muaj Feem cuam tshuam Bitcoin, Ethereum, Crypto, Blockchain, Tshuab, Kev Lag Luam. Hloov Txhua feeb. Muaj Pub Rau Txhua Yam Lus.
Ntawv loj Ib qho AbbVie bio kev nyab xeeb hood Kev lees paub ntawm AbbVie Sib sib zog nqus mus rau lub quarter thib ob ntawm lub xyoo, cov khoom lag luam tseem tsis tau rov qab los, thiab cov tub ua lag luam tab tom nrhiav kev nyab xeeb hauv kev tiv thaiv kev ua si.Ib qho kev lag luam uas tau txais txiaj ntsig los ntawm kev maj nrawm rau kev tiv thaiv yog kev kho mob, qhov twg cov tuam txhab loj muaj kev ruaj ntseg thiab, qee zaum, cov nyiaj faib tsis tu ncua.thaum lub S&P 500 index yog nqis 6.4% txog tam sim no hauv 2022, lub Cov Kev Pab Kho Mob Xaiv Cheeb Tsam SPDR Nyiaj (ticker: XLV), qhov kev sib pauv pauv nyiaj uas taug qab cov khoom kho mob hauv S&P 500, tau poob tsuas yog 1.8%. Thiab thaum lub SPDR S&P Biotech ETF (XBI), uas tsom mus rau cov khoom lag luam biotech me me, tau nqis 24.4% xyoo no, lub NYSE Arca Pharmaceutical Index (DRG), uas taug qab cov tuam txhab tshuaj loj, nce 3%.Kev sib sau los ntawm ib tus neeg loj-cap kho mob cov khoom lag luam tau txhawb nqa qhov kev ua tau zoo ntawm cov ntsuas ntsuas uas taug qab lawv. AbbVie (ABBV) cov khoom lag luam tau nce 17.7%, thiab cov khoom lag luam ntawm cov neeg muag tshuaj Cardinal Health (CAH) tau nce 22.3%.Cov tub lag luam tab tom nrhiav kev tiv thaiv kev noj qab haus huv plays yuav saib ntau yam thaum xaiv qhov chaw hauv kev kho mob los tso lawv cov thawj koom ruam. Ib qho piv txwv zoo li no yog cov nyiaj tau los ntawm cov tuam txhab, lossis feem pua ntawm lawv cov nqi them tawm txhua xyoo hauv cov nyiaj faib.Txhawm rau nrhiav kev tiv thaiv thawj koom ruam hauv kev saib xyuas kev noj qab haus huv, peb tau tshuaj xyuas cov khoom kho mob hauv S&P 500 nrog cov txiaj ntsig siab tshaj plaws hauv xyoo dhau los, raws li suav los ntawm FactSet.Cov npe uas tau tshwm sim muaj cov npe loj-cap paub hauv cov tshuaj, biotech, thiab kev faib tshuaj: AbbVie, Gilead Sciences (YOG), Merck (MRK), Cardinal Health , Bristol-Myers Squibb (BMY), thiab Amgen (AMGN).Txhua tus muaj cov nyiaj tau los ntawm ntau dua 3%, raws li FactSet, zoo tshaj qhov nruab nrab S&P 500 cov nyiaj tau los ntawm 1.4%. Txhua tus tab sis Gilead tau pom lawv cov nqi sib koom tau nce ntau xyoo no.Tuam Txhab / TickerCov txiaj ntsig faib tawm (%)Hloov pauv YTD (%)Tus nqi tsis ntev los noAbbVie / ABBV3.917.7$159.36Gilead Sciences / GILD3.9-15.2$61.58Merck / MRK3.412.3$86.07Cardinal Health / CAH3.422.3$62.98Bristol-Myers Squibb / BMY3.223.1$76.75Amgen / AMGN3.112$251.93Source: FactSet Cov khoom lag luam uas dhau qhov kev tshuaj ntsuam nrog cov nyiaj tau los ntau tshaj plaws, raws li FactSet, yog AbbVie, uas nyob rau lub Ob Hlis tshaj tawm peb lub hlis twg kev faib tawm ntawm $ 1.41 toj ib feem. Lub tuam txhab cov nyiaj faib tau nce 124% nyob rau tsib lub xyoos dhau los, raws li FactSet, thiab nws them 84% ntawm cov nyiaj tau los rau cov tswv cuab raws li cov nyiaj faib, piv rau 28.7% nruab nrab rau S&P 500.AbbVie shares tau nce xyoo no, thiab nce 41.1% nyob rau 12 lub hlis dhau los.Lwm cov khoom lag luam uas dhau los ntawm qhov screen, qhov loj-cap biotech Gilead, tshaj tawm 2.8% cov nyiaj faib tawm mus rau lub Ob Hlis, raising nws cov nyiaj faib rau $0.73 ib feem. Gilead cov nyiaj faib tau nce 48.2% hauv tsib xyoos dhau los, raws li FactSet.Sau ntawv rau Josh Nathan-Kazis ntawm [email tiv thaiv]
Kev lees paub ntawm AbbVie
Sib sib zog nqus mus rau lub quarter thib ob ntawm lub xyoo, cov khoom lag luam tseem tsis tau rov qab los, thiab cov tub ua lag luam tab tom nrhiav kev nyab xeeb hauv kev tiv thaiv kev ua si.
Ib qho kev lag luam uas tau txais txiaj ntsig los ntawm kev maj nrawm rau kev tiv thaiv yog kev kho mob, qhov twg cov tuam txhab loj muaj kev ruaj ntseg thiab, qee zaum, cov nyiaj faib tsis tu ncua.
thaum lub
S&P 500 index yog nqis 6.4% txog tam sim no hauv 2022, lub
Cov Kev Pab Kho Mob Xaiv Cheeb Tsam SPDR Nyiaj (ticker: XLV), qhov kev sib pauv pauv nyiaj uas taug qab cov khoom kho mob hauv S&P 500, tau poob tsuas yog 1.8%.
Thiab thaum lub
SPDR S&P Biotech ETF (XBI), uas tsom mus rau cov khoom lag luam biotech me me, tau nqis 24.4% xyoo no, lub
NYSE Arca Pharmaceutical Index (DRG), uas taug qab cov tuam txhab tshuaj loj, nce 3%.
Kev sib sau los ntawm ib tus neeg loj-cap kho mob cov khoom lag luam tau txhawb nqa qhov kev ua tau zoo ntawm cov ntsuas ntsuas uas taug qab lawv.
AbbVie (ABBV) cov khoom lag luam tau nce 17.7%, thiab cov khoom lag luam ntawm cov neeg muag tshuaj
Cardinal Health (CAH) tau nce 22.3%.
Cov tub lag luam tab tom nrhiav kev tiv thaiv kev noj qab haus huv plays yuav saib ntau yam thaum xaiv qhov chaw hauv kev kho mob los tso lawv cov thawj koom ruam. Ib qho piv txwv zoo li no yog cov nyiaj tau los ntawm cov tuam txhab, lossis feem pua ntawm lawv cov nqi them tawm txhua xyoo hauv cov nyiaj faib.
Txhawm rau nrhiav kev tiv thaiv thawj koom ruam hauv kev saib xyuas kev noj qab haus huv, peb tau tshuaj xyuas cov khoom kho mob hauv S&P 500 nrog cov txiaj ntsig siab tshaj plaws hauv xyoo dhau los, raws li suav los ntawm FactSet.
Cov npe uas tau tshwm sim muaj cov npe loj-cap paub hauv cov tshuaj, biotech, thiab kev faib tshuaj: AbbVie,
Gilead Sciences (YOG),
Merck (MRK),
Cardinal Health ,
Bristol-Myers Squibb (BMY), thiab
Amgen (AMGN).
Txhua tus muaj cov nyiaj tau los ntawm ntau dua 3%, raws li FactSet, zoo tshaj qhov nruab nrab S&P 500 cov nyiaj tau los ntawm 1.4%. Txhua tus tab sis Gilead tau pom lawv cov nqi sib koom tau nce ntau xyoo no.
Source: FactSet
Cov khoom lag luam uas dhau qhov kev tshuaj ntsuam nrog cov nyiaj tau los ntau tshaj plaws, raws li FactSet, yog AbbVie, uas nyob rau lub Ob Hlis tshaj tawm peb lub hlis twg kev faib tawm ntawm $ 1.41 toj ib feem. Lub tuam txhab cov nyiaj faib tau nce 124% nyob rau tsib lub xyoos dhau los, raws li FactSet, thiab nws them 84% ntawm cov nyiaj tau los rau cov tswv cuab raws li cov nyiaj faib, piv rau 28.7% nruab nrab rau S&P 500.
AbbVie shares tau nce xyoo no, thiab nce 41.1% nyob rau 12 lub hlis dhau los.
Lwm cov khoom lag luam uas dhau los ntawm qhov screen, qhov loj-cap biotech Gilead, tshaj tawm 2.8% cov nyiaj faib tawm mus rau lub Ob Hlis, raising nws cov nyiaj faib rau $0.73 ib feem. Gilead cov nyiaj faib tau nce 48.2% hauv tsib xyoos dhau los, raws li FactSet.
Sau ntawv rau Josh Nathan-Kazis ntawm [email tiv thaiv]
Tau qhov twg los: https://www.barrons.com/articles/healthcare-stock-picks-dividends-51650468547?siteid=yhoof2&yptr=yahoo